Lynx Capital Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.12M Buy
45,453
+4,600
+11% +$420K 1.67% 21
2026
Q1
$4.19M Sell
40,853
-196
-0.5% -$22.1K 1.95% 17
2025
Q4
$5.14M Buy
41,049
+16,000
+64% +$2.04M 2.36% 12
2025
Q3
$3.36M Sell
25,049
-726
-3% -$95.3K 1.56% 27
2025
Q2
$3.51M Sell
25,775
-369
-1% -$48.7K 1.69% 19
2025
Q1
$3.47M Buy
26,144
+5,242
+25% +$667K 1.79% 14
2024
Q4
$2.36M Sell
20,902
-94
-0.4% -$10.9K 1.36% 37
2024
Q3
$2.39M Buy
20,996
+194
+0.9% +$21.3K 1.55% 37
2024
Q2
$2.16M Buy
20,802
+98
+0.5% +$10.4K 1.49% 35
2024
Q1
$2.35M Buy
20,704
+1,075
+5% +$123K 1.59% 33
2023
Q4
$2.16M Buy
+19,629
New +$1.96M 1.57% 32

Other funds holding ABT

Lynx Capital Group's ABT Position: Q2 2026 in Review

Lynx Capital Group increased its Abbott (ABT) stake by 11% in Q2 2026, buying an estimated $420K and bringing the position to 45,453 shares worth $4.12M. The position accounts for 1.67% of the portfolio, ranked #21.

Lynx Capital Group first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.14M in Q4 2025. 2,837 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Lynx Capital Group held 45,453 shares of Abbott worth $4.12M as of Q2 2026.
  • Lynx Capital Group bought 4,600 Abbott shares in Q2 2026, an estimated $420K.
  • Abbott made up 1.67% of Lynx Capital Group's portfolio in Q2 2026, its #21 holding.
  • Lynx Capital Group first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Lynx Capital Group's Abbott position peaked at $5.14M in Q4 2025.
  • 2,837 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Lynx Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.